Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Spyre Therapeutics (NASDAQ:SYRE) CEO Sells $1,380,150.00 in Stock

Summary
Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) CEO Cameron Turtle sold 15,000 shares of the company’s stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $92.01, for a total value of $1,380,150.00. Following the sale, the chief executive officer owned 537,540 shares in the company, valued […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

thecerbatgem.comthecerbatgem.com

Spyre Therapeutics (NASDAQ:SYRE) Insider Sells $2,633,770.99 in Stock

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) insider Heidy King-Jones sold 28,933 shares of the firm’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $91.03, for a total value of $2,633,770.99. Following the sale, the insider owned 2,845 shares in the company, valued at approximately […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

thecerbatgem.com broke the news on Monday, October 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Waltham, Massachusetts icon

Waltham, Massachusetts

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal